Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes

Clinical Endocrinology

Volumn 76, Issue 3, 2012, Pages 425-430

  Xu, Xinghua ^a   Shi, Yuhua ^a   Cui, Yuqian ^a   Ma, Jinlong ^a   Che, Li ^b   Chen, Zi Jiang ^a  

^a SHANDONG UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AMENORRHEA; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHINESE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HIP CIRCUMFERENCE; HUMAN; INSULIN METABOLISM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; OLIGOMENORRHEA; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AMENORRHEA; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BODY MASS INDEX; CHINA; CHOLESTEROL; FEMALE; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; INSULIN; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LUTEINIZING HORMONE; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; PROLACTIN; RETROSPECTIVE STUDIES; TESTOSTERONE; TRIGLYCERIDES; YOUNG ADULT;

EID: 84863071301     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04194.x     Document Type: Article

References (24)

1. Azziz, R., Woods, K.S., Reyna, R., et al. (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism, 89, 2745-2749. (Pubitemid 38766360)
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81, 19-25.
3. Cupisti, S., Kajaia, N., Dittrich, R., et al. (2008) Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome. European Journal of Endocrinology, 158, 711-719. (Pubitemid 351639610)
4. Barber, T.M., Wass, J.A., McCarthy, M.I., et al. (2007) Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clinical Endocrinology (Oxford), 66, 513-517. (Pubitemid 46434931)
5. Chae, S.J., Kim, J.J., Choi, Y.M., et al. (2008) Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Human Reproduction, 23, 1924-1931. (Pubitemid 352020025)
6. Zhang, H.Y., Zhu, F.F., Xiong, J., et al. (2009) Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG, 116, 1633-1639.
7. Shi, Y., Gao, X., Sun, X., et al. (2008) Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Fertility and Sterility, 90, 1139-1143.
8. Rizzo, M., Berneis, K., Hersberger, M., et al. (2009) Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Human Reproduction, 24, 2286-2292.
9. Carmina, E., &, Azziz, R., (2006) Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertility and Sterility, 86 (Suppl. 1), S7-S8.
10. Ehrmann, D.A., (2005) Polycystic ovary syndrome. New England Journal of Medicine, 352, 1223-1236.
11. Archer, J.S., &, Chang, R.J., (2004) Hirsutism and acne in polycystic ovary syndrome. Best Practice & Research. Clinical Obstetrics & Gynaecology, 18, 737-754. (Pubitemid 40424608)
12. Balen, A.H., Laven, J.S., Tan, S.L., et al. (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update, 9, 505-514. (Pubitemid 38072143)
13. Legro, R.S., Castracane, V.D., &, Kauffman, R.P., (2004) Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstetrical and Gynecological Survey, 59, 141-154. (Pubitemid 38140845)
14. Levy, J.C., Matthews, D.R., &, Hermans, M.P., (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care, 21, 2191-2192. (Pubitemid 28549174)
15. Carmina, E., Koyama, T., Chang, L., et al. (1992) Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? American Journal of Obstetrics and Gynecology, 167, 1807-1812. (Pubitemid 23009328)
16. Wild, R.A., Carmina, E., Diamanti-Kandarakis, E., et al. (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. Journal of Clinical Endocrinology and Metabolism, 95, 2038-2049.
17. Wierzbicki, A.S., (2008) Lipoproteins: from A to B and maybe C-III. International Journal of Clinical Practice, 62, 674-676. (Pubitemid 351533672)
18. Christakou, C.D., &, Diamanti-Kandarakis, E., (2008) Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (London, England), 4, 583-594.
19. T Rk O Lu, I., Kafkasli, A.E., Meydanli, M.M., et al. (2011) Independent predictors of cardiovascular risk in polycystic ovarian syndrome. Gynecological Endocrinology, [Epub ahead of print].
20. Wijeyaratne, C.N., Seneviratne Rde, A., Dahanayake, S., et al. (2011) Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Human Reproduction, 26, 202-213.
21. Goumenou, A.G., Matalliotakis, I.M., Koumantakis, G.E., et al. (2003) The role of leptin in fertility. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 106, 118-124. (Pubitemid 36120454)
22. Gambineri, A., Pelusi, C., Vicennati, V., et al. (2002) Obesity and the polycystic ovary syndrome. International Journal of Obesity and Related Metabolic Disorders, 26, 883-896. (Pubitemid 34756169)
23. Escobar-Morreale, H.F., &, San Millan, J.L., (2007) Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology and Metabolism, 18, 266-272. (Pubitemid 47332217)
24. Katsikis, I., Karkanaki, A., Misichronis, G., et al. (2011) Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 156, 181-185.